DXCM – DexCom, Inc.
DexCom, Inc.DXCM
$79.92Name : DexCom, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $29,806,235,648.00
EPSttm : 2.54
DexCom, Inc.
$79.92
1.42%$1.15
DXCM — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
4.28
Margin Of Safety %
1
Put/Call OI Ratio
0.96
EPS Next Q Diff
-0.09
EPS Last/This Y
0.61
EPS This/Next Y
0.43
Price
79.9
Target Price
99.36
Analyst Recom
1.39
Performance Q
-11.98
Upside
11.7%
Beta
1.44
Ticker: DXCM
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | DXCM | 85.93 | 0.91 | 0.60 | 79133 |
| 2026-10-13 | DXCM | 85.06 | 0.90 | 1.46 | 79920 |
| 2026-10-14 | DXCM | 83.48 | 0.90 | 3.94 | 80878 |
| 2026-10-15 | DXCM | 87.71 | 0.93 | 0.34 | 82972 |
| 2026-10-16 | DXCM | 86.05 | 0.89 | 0.58 | 87228 |
| 2026-10-19 | DXCM | 85.96 | 0.89 | 0.21 | 83368 |
| 2026-10-20 | DXCM | 85.76 | 0.88 | 1.34 | 83941 |
| 2026-10-21 | DXCM | 80.26 | 0.89 | 0.49 | 84665 |
| 2026-10-22 | DXCM | 78.34 | 0.89 | 1.75 | 86217 |
| 2026-10-23 | DXCM | 77.93 | 0.90 | 0.50 | 87085 |
| 2026-10-26 | DXCM | 78.55 | 0.92 | 0.17 | 84610 |
| 2026-10-27 | DXCM | 78.56 | 0.91 | 2.76 | 85834 |
| 2026-10-28 | DXCM | 78.58 | 0.93 | 1.19 | 88856 |
| 2026-10-29 | DXCM | 79.89 | 0.95 | 0.87 | 90010 |
| 2026-10-30 | DXCM | 82.3 | 0.95 | 0.41 | 95482 |
| 2026-11-02 | DXCM | 84.77 | 0.97 | 0.24 | 87672 |
| 2026-11-03 | DXCM | 82.89 | 0.96 | 1.03 | 88971 |
| 2026-11-04 | DXCM | 88.47 | 0.96 | 0.61 | 91053 |
| 2026-11-05 | DXCM | 84.47 | 0.96 | 0.31 | 92328 |
| 2026-11-06 | DXCM | 79.39 | 0.93 | 0.59 | 94515 |
| 2026-11-09 | DXCM | 81.05 | 0.96 | 0.92 | 91201 |
| 2026-11-10 | DXCM | 79.92 | 0.96 | 0.19 | 91588 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | DXCM | 85.92 | 10.4 | -58.5 | 2.66 |
| 2026-10-13 | DXCM | 85.10 | 10.4 | -96.8 | 2.66 |
| 2026-10-14 | DXCM | 83.49 | 10.4 | -107.5 | 2.66 |
| 2026-10-15 | DXCM | 87.71 | 10.5 | -46.3 | 2.66 |
| 2026-10-16 | DXCM | 86.06 | 10.5 | -107.9 | 2.66 |
| 2026-10-19 | DXCM | 85.95 | 10.5 | -86.3 | 2.66 |
| 2026-10-20 | DXCM | 85.95 | 10.5 | -86.3 | 2.66 |
| 2026-10-21 | DXCM | 85.76 | 10.5 | -88.0 | 2.66 |
| 2026-10-22 | DXCM | 78.33 | 10.5 | -114.7 | 2.66 |
| 2026-10-23 | DXCM | 77.93 | 10.5 | -91.3 | 2.66 |
| 2026-10-26 | DXCM | 78.55 | 10.5 | -75.4 | 2.66 |
| 2026-10-27 | DXCM | 78.57 | 10.5 | -85.9 | 2.66 |
| 2026-10-28 | DXCM | 78.62 | 10.5 | -84.1 | 2.66 |
| 2026-10-29 | DXCM | 79.93 | 10.5 | -64.5 | 2.66 |
| 2026-10-30 | DXCM | 82.30 | 10.5 | -48.5 | 2.66 |
| 2026-11-02 | DXCM | 84.76 | 10.5 | -29.4 | 2.66 |
| 2026-11-03 | DXCM | 82.97 | 5.4 | -55.6 | 2.70 |
| 2026-11-04 | DXCM | 88.47 | 5.4 | 15.5 | 2.70 |
| 2026-11-05 | DXCM | 84.46 | 5.4 | -121.4 | 2.70 |
| 2026-11-06 | DXCM | 79.40 | 5.4 | -23.7 | 2.70 |
| 2026-11-09 | DXCM | 81.05 | 5.4 | 85.1 | 2.70 |
| 2026-11-10 | DXCM | 79.90 | 5.4 | 37.7 | 2.70 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | DXCM | -2.41 | 1.03 | 3.78 |
| 2026-10-13 | DXCM | -2.41 | 1.03 | 3.78 |
| 2026-10-14 | DXCM | -2.41 | 1.03 | 3.78 |
| 2026-10-15 | DXCM | -2.41 | 1.03 | 3.78 |
| 2026-10-16 | DXCM | -2.41 | 1.03 | 3.78 |
| 2026-10-19 | DXCM | -2.39 | 0.79 | 3.78 |
| 2026-10-20 | DXCM | -2.41 | 0.79 | 3.78 |
| 2026-10-21 | DXCM | -2.41 | 0.79 | 3.78 |
| 2026-10-22 | DXCM | -2.41 | 0.79 | 3.78 |
| 2026-10-23 | DXCM | -2.41 | 0.79 | 3.78 |
| 2026-10-26 | DXCM | -2.41 | 0.97 | 3.78 |
| 2026-10-27 | DXCM | -2.41 | 0.97 | 4.23 |
| 2026-10-28 | DXCM | -2.41 | 0.97 | 4.23 |
| 2026-10-29 | DXCM | -2.45 | 0.97 | 4.23 |
| 2026-10-30 | DXCM | -2.45 | 0.97 | 4.23 |
| 2026-11-02 | DXCM | -2.48 | 0.15 | 4.28 |
| 2026-11-03 | DXCM | -2.48 | 0.15 | 4.28 |
| 2026-11-05 | DXCM | -2.48 | 0.15 | 4.28 |
| 2026-11-06 | DXCM | -2.48 | 0.15 | 4.28 |
| 2026-11-09 | DXCM | -2.48 | 1.04 | 4.28 |
| 2026-11-10 | DXCM | -2.48 | 1.04 | 4.28 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.73
Avg. EPS Est. Current Quarter
0.72
Avg. EPS Est. Next Quarter
0.64
Insider Transactions
-2.48
Institutional Transactions
1.04
Beta
1.44
Average Sales Estimate Current Quarter
1384
Average Sales Estimate Next Quarter
1312
Fair Value
80.37
Quality Score
97
Growth Score
98
Sentiment Score
67
Actual DrawDown %
51.5
Max Drawdown 5-Year %
-66.3
Target Price
99.36
P/E
31.32
Forward P/E
25.43
PEG
1.21
P/S
5.84
P/B
11.76
P/Free Cash Flow
27.14
EPS
2.55
Average EPS Est. Cur. Y
2.7
EPS Next Y. (Est.)
3.13
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
19.41
Relative Volume
0.7
Return on Equity vs Sector %
12.8
Return on Equity vs Industry %
28.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
37.7
◆
DXCM
Healthcare
$79.92
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.2
Range 1M
24.5%
Sup Dist
0.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
29.3%
EPS NY
16.3%
52W%
65.4%
Long-Term Value
Quality companies, undervalued
WATCH
🟡 HOLD
+23.6% upside
Upside
+23.6%
Quality
97
MoS
1%
DXCM — P/E HistoricalDiagnostics & Research
DexCom, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 11000
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DXCM
Latest News
—
Caricamento notizie per DXCM…
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading